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At Least Three Transporters Likely
Mediate Threonine Uptake Needed
for Mouse Embryonic Stem Cell
Proliferation
Tara M. Formisano* and Lon J. Van Winkle
Department of Biochemistry, Midwestern University College of Health Science, Downers Grove, IL, USA
Stem cells are at the forefront of current regenerative and biomedical research. Thus,
there exists an imperative and urgent need to understand the mechanisms that drive
stem cell function in order to exploit their use as a therapeutic tool. Amino acids are
potent inducers of signaling cascades that drive stem cell proliferation and differentiation.
With a focus on mouse embryonic stem (mES) cells, Threonine (Thr) is the only amino
acid required in culture media for mES cell proliferation. Current research associates this
need for Thr with threonine dehydrogenase (TDH), which catabolizes Thr to glycine and
acetyl-CoA inmES cells. This theory depends, in part, on the ability of 3- hydroxynorvaline
(3-HNV) to inhibit both TDH and mES cell proliferation. However, the concentration of
3-HNV needed to inhibit mES cell proliferation is more than an order of magnitude less
than its apparent Ki for TDH inhibition. Additionally, 3-HNV inhibits human embryonic
stem (hES) cell proliferation, but hES cells do not express a functional tdh gene. Such
findings indicate another mechanism for Thr stimulated mES and hES cell proliferation.
Since amino acid transporters may be inducers of signaling cascades, we characterized
the Thr transport systems in mES cells. We found that there is a Na+-dependent and a
Na+-independent component of substrate-saturable transport, with the Na+-dependent
component predominating. We also found that of 20 amino acids tested, the amino acids
that were the strongest inhibitors of the Na+-dependent component of radiolabeled Thr
transport were Ser, Cys, 4-OH-Pro, Asn, Met, and non-radiolabeled Thr itself. Such
findings are consistent with characteristics of the ASC transport system, suggesting
that this ASC system is responsible for the majority of Thr transport in mES cells.
We confirmed expression of mRNA encoding the ASC system transporters, ASCT1
and ASCT2, in mES cells using RT-PCR. In conclusion, mES cells likely express at
least three transporters of Thr; at least two Na+-dependent transporters and one
Na+-independent one.
Keywords: mES cells, cell proliferation, threonine, amino acid transport system ASC, amino acid
transport system L
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INTRODUCTION
Stem cells are one of the primary focuses in current regenerative
medicine and biomedical research.With their vast developmental
potential, proliferative competence, and genetic stability, stem
cells have noteworthy therapeutic potential. In fact, stem cells
have the potential to treat a wide variety of diseases and injuries
including neurological disease, blindness, Type I Diabetes
Mellitus, Parkinson’s disease, Leukemia, and spinal cord injuries
(Amit et al., 2000; Puri and Nagy, 2012). Thus, there is a race to
understand stem cell biology in order to exploit their potential
uses.
In an effort to understand stem cell function, some
research has focused on the role of amino acids in stem
cell proliferation and differentiation (Van Winkle, 2013). mES
cell proliferation and maintenance of the undifferentiated state
depends exclusively on the presence of Thr in the culturemedium
(Alexander et al., 2011). These authors proposed a need for
Thr owing to its rapid catabolism via threonine dehydrogenase
(TDH), an enzyme abundant in mES cells. The selective TDH
inhibitor, 3-HNV, inhibits mES cell proliferation, and Thr rescues
the cells from this inhibition (Wang et al., 2009). A sharp
contradiction, however, can be seen when comparing mES cells
and hES cells. hES cells seem to rely in a similar way on Thr for
proliferation, but hES cells produce inactive TDH (Darling et al.,
2000; Edgar, 2002; Van Winkle et al., 2014). In addition, the Thr
and 3-HNV concentrations needed for mES cell proliferation or
inhibition of proliferation, respectively, are more than an order
of magnitude less than the apparent Km and Ki values for the
interaction of Thr or 3-HNVwith TDH (VanWinkle et al., 2014).
These results support the conclusion that TDH is not the site of
3-HNV and Thr action in hES cells, and it may not be the only
site of their action in mES cells.
Previous studies attribute the need for Thr by mES cells
to its rapid catabolism via TDH. These studies found that the
mRNA levels of TDH were 1000 times higher in mES cells
compared to differentiated cells (Ochocki and Simon, 2013).
Much research is consistent with the conclusion that TDH
catabolism of Thr is responsible for the unique one carbon
metabolic state of mES cells (Han et al., 2013). Specifically,
TDH is a mitochondrial enzyme that hydrolyzes Thr into glycine
and acetyl-coA (Han et al., 2013). Glycine is used to promote
mES cell one carbon metabolism while acetyl-coA is oxidized in
the TCA cycle (Han et al., 2013). This one carbon metabolism
supports the purine and the pyrimidine (thymidine) biosynthesis
needed for mES cell proliferation (Ochocki and Simon, 2013).
Furthermore, inhibition of TDH eventually causes mES cell
death (Han et al., 2013). Thus, Thr breakdown products supply
metabolic pathways with substrates needed for rapid mES cell
proliferation.
Threonine’s role in mES cell proliferation is likely more
complex, however. Studies indicate that Thr is a very potent
activator of several critical signaling pathways. One such study
explored Thr’s role in regulating embryonic stem (ES) cell
transition through the G1/S phase of the cell cycle (Ryu and
Han, 2011). Specifically, this study found that Thr stimulates
ES cell transition through the G1/S phase by activating
lipid raft/caveolae-dependent signaling pathways, including
PI3K/Akt, MAPKs, mTOR, p7056k, and 4E-BP1 (Ryu and Han,
2011). The induction of these signaling pathways leads to the
transcription of c-Myc, which is a potent regulator of cell
proliferation (Ryu and Han, 2011). Moreover, this study also
found that Thr will restore and increase cyclin D1 and cyclin E,
both of which are the rate limiting activators on the G1 to S phase
transition in the cell cycle required for proliferation (Ryu and
Han, 2011). The lipid raft dependent signaling could be through a
direct association of Thr and its transporter with the raft (Ryu and
Han, 2011). Thr also may be needed intracellularly for signaling,
which would depend on uptake of Thr by the cells (Ryu and Han,
2011). All of these studies support the need to characterize Thr
transport in ES cells.
Amino transport systems were originally categorized
according to their substrate selectivity (cationic, anionic,
or zwitterionic amino acids) and Na+ dependence (Van
Winkle, 2013). Numerous amino acid transport systems have
been characterized and the transporter proteins comprising the
systems identified (Placín et al., 1998; VanWinkle, 2013). Systems
that could transport Thr well include the Na+–independent
systems, L (named for Leu) and b0,+ (selective for Arg), and the
Na+-dependent systems, B0,+ (selective for Leu, Ile, and Trp),
A (named for Ala) and ASC (named for Ala, Ser, and Cys; Van
Winkle, 2013). Of these, system ASC is particularly attractive
as a possible Thr transporter in mES cells because this system
tolerates hydroxyl and sulfahydryl groups at C3 or C4 very well
(Utsunomiya-Tate et al., 1996; Pinilla-Tenas et al., 2003). Thr
has such a hydroxyl group rendering if a good substrate for this
system. Nevertheless, when amino acid transport has not been
studied in a particular cell type, it should be characterized first,
rather than assuming that certain amino acid transporters are
present in those cells (Van Winkle, 2013). Since Thr transport
has not been characterized previously in mES cells, we began to
characterize it as described in these studies.
METHODS
mES Cell Culture
ATCC American Tissue Type Culture Collection CE1 Mouse
Embryonic Stem Cells were placed in T75 Tissue Culture
Flasks with mES cell media for 2 days. Media included DMEM
F12 (Gibco), Leukemia Inhibiting Factor (Gibco), Fetal Bovine
Serum (Bio west), non-essential amino acid (Gibco), Penicillin-
streptomycin (Hydroclone) and glutamine solution containing
DMEM F12 (Gibco), glutamine (Sigma), and 2-mercaptoethanol
(Bio Rad). After 2 days of growth, the cells were trypsinized with
Tryspin-EDTA (Gibco) for 5min and then collected in a 15ml
conical centrifuge tube. The cells were spun down at 3400 rpm
for 1min and then re-suspended in 5ml of mES cell media by
trituration. Cells were then placed in approximately 20ml of mES
cell media in a 50ml conical tube and counted using a TC20
Automated Cell Counter (Bio Rad). They were then brought to
a concentration of 2 × 105 cells/ml mES cell media. 1ml of mES
cell suspension was plated into each well in a 6 well tissue culture
treated plate and then placed in 5% CO2, 37
◦C, 100% humidity
incubator (Binder) for 1 day. On day 2, media was replaced
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with fresh mES cell media. The cells were placed back into the
incubator. On day 3, experimental procedures were performed.
Time Course
mES cell media was aspirated off of the 6 well plates containing
mES cells using an in house vacuum system. 1ml of the different
uptake buffers (with Na+ and without Na+) containing 50 uM-
radioactive labeled Thr was added to their respective wells. The
uptake buffers tested include those containing 140mM NaCl,
LiCl, Choline Cl, and KCl, and 280mM Mannitol. The uptake
buffer stock solution also contained 25mMHEPES+ Tris (pH=
6.8), 5.4mM KCl, 0.8mMMgSO4, 5mM glucose, 1.8mM CaCl2,
and 50 uM [3H]-Thr (20 Ci/mmol in stock solution supplied
by American Radiolabeled Chemicals, Saint Louis, MO). The
cells were incubated up to 10min at 37◦C, 100% Humidity
(Napco). After each incubation period, 20 uL of the sample was
taken from each well and placed into scintillation vials. The
remaining radioactive treatment was aspirated off. Cells were
then washed 6 times with the appropriate with Na+ or without
Na+ uptake buffer (NOTE: This buffer did not contain any
radiolabeled Thr). The 6th wash was collected and placed in
a second set of scintillation vials to check for thoroughness of
washing. The cells were then treated with 1ml 4% SDS detergent
for 2min. The sample was collected into a 3rd set of scintillation
vials. 5ml of Scintillation cocktail Econ2 (Fischer Scientific)
was added to all scintillation vials. All vials were placed in a
Beckmann LS6500 Beta liquid scintillation counter and counted
for 10min. Experiments were performed 1–3 times with 1–3
replicate determinations as indicated in Figure legends.
Radiolabeling Amino Acid Inhibitor
Experiment
mES cell media was aspirated off of the 6 well plates containing
mES cells using an in house vacuum system. A radioactive
solution containing uptake buffer, 50 uM radiolabeled Thr, and
10mM of various potential amino acid inhibitors (Glu, Ser, Lys,
Gly, Leu, MeAIB, Pro, Asp, Thr, Sar, Cys, Asn, Ala, Met, His,
Gln, Arg, Tyr, BCH at 5mM, 4-OH-Pro) was prepared. Each
study was repeated using the Na+ containing uptake buffer and
with the no-Na+ containing uptake buffer, Mannitol. The stock
uptake buffer solution contained 25mM HEPES + Tris (pH =
6.8), 5.4mM KCl, 0.8mMMgSO4, 5mM glucose, 1.8mM CaCl2,
and 50 uM [3H]-Thr. The Na+ containing buffer also contained
140mM NaCl and the no-Na+ containing uptake buffer also
contained 280mMMannitol. 1ml of the radiolabeled Thr uptake
solution was added to the appropriate well in the 6 well plates
and then incubated for 10min at 37◦C, 100% humidity. After
10min, 20 uL of the sample was taken from each well and placed
into scintillation vials. The remaining radioactive treatment was
aspirated off. The cells were washed 6 times with the appropriate
NaCl or Mannitol uptake buffer. The 6th wash was collected
and placed in a second set of scintillation vials to check for
thoroughness of washing. The cells were then treated with 1ml
4% SDS detergent for 1min. The sample was collected into the
scintillation vials. 5ml of Scintillation cocktail Econ2 (Fischer
Scientific) was added to all scintillation vials. All vials were placed
in a Beckmann LS6500 Beta liquid scintillation counter and
counted for 10min. Experiments were performed 1–3 times with
1–3 replicate determinations as indicated in Figure legends.
Once the less complete inhibitors of Thr uptake were
identified from themore complete inhibitor series above, Leu and
Pro, were used in the same experimental procedure using 0.5, 1.0,
5.0, 10.0, 20.0mM of Leu and Pro, respectively, and 20mM non-
radioactive Thr in the NaCl uptake buffer. Our control was 50 uM
3H Thr uptake solution with no amino acid inhibitor.
Once the complete inhibitors of Thr uptake were identified
from the complete inhibitor series, we conducted the same
experimental procedure using 500 uM of only those complete
inhibitors (Ser, Ala, Thr, Cys, Asn, 3-HNV, Met, 4-OH-Pro) in
both the NaCl uptake buffer and no-Na+ uptake buffer, Choline
Chloride. Our control was 50 uM 3HThr uptake solution with no
amino acid inhibitor.
RT-PCR
For RNA isolation, approximately 5 × 106 cells were spun down
to a pellet at 300 × g for 5min. 350 uL of Buffer RLT was
added to lyse the pelleted cells. Total RNA was then isolated
from the cells using the RNeasy Mini RNA Isolation Kit using
the manufacturer protocol (Qiagen) (NOTE: The QIAshredder
spin column protocol option was used). The RNA was quantified
by measuring the absorbance at 260 nm. Typical total RNA yield
was ∼2300 ng/ul. The technique for RT-PCR was performed
using 2 ug total RNA from the mES cells and the QIAGEN
OneStep RT-PCR kit protocol that was recommended by the
manufacturer. 0.6 uM PrimeTime qPCR Primers were used
(Integrated DNA Technologies). The Slc1a4 and Slc1a5 qPCR
primers amplify a ∼150 bp PCR product. The sequence of the
primers for Slc1a4 (ASCT1; Marin et al., 2000) are as follows:
forward primer:
5′-TCATCCCTTCCACATCTGTTAC-3′; reverse primer:
5′- CCTGTTCCCTTCCAATCTTGT-3′. The sequence of the
primers for Slc1a5 (ASCT2; Marin et al., 2000) are as follows:
forward primer:
5′- CCATTCTTCTCCTCTACACACTTC-3′; reverse primer:
5′- CCTCTCATCTACTTCCTCTTCAC-3′. The no-template
sample consisted of molecular biology grade water instead of
RNA. The PrimeTime qPCR Primer stock solution was made to a
concentration of 10× according to the manufacturer’s protocol
(Integrated DNA Technologies). The RT-PCR conditions used
were 30min at 50◦C, 15min at 95◦C, 1min at 94◦C, 1min at
58◦C, 1min at 72◦C, followed by 40 cycles of 1min at 94◦C, and
then 10min at 72◦C.
Gel Electrophoresis
The gel was loaded and samples were electrophoresed at 100V
for 45min in 1× TAE buffer with ethidium bromide (0.5 ug/ml).
The DNA was visualized using a UV transilluminator. Samples
of cDNA were sent to Molecular Cloning Laboratories (San
Francisco, CA) for sequencing. The sequences of the cDNAs
corresponded to the sequences anticipated for those segments
of ASCT1 and ASCT2 mRNA. The Slc1a4 forward and reverse
primers (ASCT1) had a 98% match. The Slc1a5 forward and
reverse primers (ASCT2) had a 99% match (Molecular Cloning
Laboratories).
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FIGURE 1 | Time course of 50 uM [3H]-Thr uptake in the presence of
140mM NaCl, LiCl, Choline Cl, or KCl, or 280mM Mannitol. (A) Uptake
was measured at 2.5, 5, and 10min and increased significantly with time
(p < 0.0001) (n = 3; 1 replicate experiment for each time point). (B) Time
course of 50 uM [3H]-Thr uptake in the presence of 140mM NaCl at 0, 1, 2,
and 3min. Uptake increased significantly with time (r = 0.99, p = 0.01, 1
replicate experiment for each time point).
RESULTS
Threonine has a Na+-Dependent and
Na+-Independent Component of Transport
From the time course studies, Thr uptake was much more rapid
in the presence of Na+ than in its absence (Figure 1A, p < 0.003,
Effect Size= 0.96). In both instances, Thr uptake increased nearly
linearly with time for at least 10min (p < 0.0001 for uptake in the
absence of Na+ shown in the figure and in the presence of Na+
in a separate series of experiments with three determinations at
each time point). The correlation coefficients for the increases
of Thr uptake with time were: rNa+ = 0.97, rno Na+ = 0.96.
The correlation coefficient for the increase in Thr uptake over
3min was r = 0.99 (Figure 1B). Some binding of Thr to the cells
also likely occurred since [3H]-Thr was associated with mES cells
even after their exposure to [3H]-Thr for only a few seconds, as
indicated at the 0 time point in Figure 1B.
Threonine Transport Is Inhibited to Varying
Degrees by Different Amino Acids in the
Presence or Absence of Na+
In the presence of Na+, [3H]-Thr transport was significantly
inhibited (p < 0.05) by Ser, Gly, Leu, Pro, Sar, Cys Asn, Ala,
FIGURE 2 | Percent uptake of 50 uM [3H]-Thr in the presence of
140mM NaCl and 10mM of the amino acid indicated. (A) A 1-sample
t-test determined the more complete inhibitors (**p < 0.0001) and other
statistically significant inhibitors (*p < 0.05) (n = 6 for each column; 3
determinations obtained in each of 2 independent experiments). (B) Percent
uptake of 50 uM [3H]-Thr in the presence of 280mM Mannitol and 10mM of
the amino acid indicated. A 1-sample t-test determined the more complete
inhibitor (**p < 0.0001) and other statistically significant inhibitors (*p < 0.05)
(n = 6 for each column; 3 determinations obtained in each of 2 independent
experiments).
Met, His, Gln, BCH, 4-OH-Pro, and non-radioactive Thr itself
(Figure 2A). Of these, the more complete inhibitors were Ser,
Thr, Cys, Asn, Ala, Met, and 4-OH-Pro (p < 0.0001; Figure 2A).
Less complete inhibitors were Gln, Gly, Leu, Pro, His, Sar, and
BCH. Arg, Tyr, Glu, Lys, meAIB, and Asp did not inhibit [3H]-
Thr uptake to a statistically significant extent (Figure 2A). See
Table S1 in the supplemental materials for a full list of the amino
acids and their abbreviations.
In the absence of Na+, [3H]-Thr transport was significantly
inhibited (p < 0.05) by Ser, Leu, MeAIB, Thr, Cys, Asn, Met,
Gln, Tyr, and BCH (Figure 2B). Notably, Leu, Tyr, and BCH
were better inhibitors in the absence than in the presence of
Na+, while Asn and Ala were better inhibitors in the presence
of Na+ (Figure 2A vs. Figure 2B; Table 1). Cys was the strongest
inhibitor in both conditions (p < 0.0001) (Figures 2A,B). [3H]-
Thr transport was not significantly inhibited by Glu, Lys, Gly,
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TABLE 1 | Mean % [3H]-Thr Uptake in 140mM NaCl vs. 280mM Mannitol
and the amino acid indicated (from Figures 2A,B).
Amino acid NaCl uptake buffer (%) Mannitol uptake buffer (%)
Ser 9.12 37.05
Thr 8.00 25.53
Asn 8.68 57.05
Met 19.90 31.10
Gln 36.44 63.90
Leu 54.53 19.48
BCH 71.78 44.13
Tyr 83.64 63.65
Ala 9.56 86.20
Cys 4.40 14.78
MeAIB, Pro, Asp, Sar, Ala, His, Arg, or 4-OH-Pro in the absence
of Na+.
Establishing Weaker vs. Partial Inhibition
by Leu and Pro
Of the incomplete inhibitors of Thr uptake in the presence
of Na+ (Figure 1A), Leu and Pro were found to be weak
rather than partial inhibitors. Thr uptake decreased as the
Leu or Pro concentration increased to 20mM (Figures 3A,B)
indicating weak inhibition. Because Leu and Pro were weak
inhibitors, they probably inhibited the same components of
Thr transport. Furthermore, when Leu and Pro combined and
examined as inhibitors of Thr uptake, Leu and Pro did not
inhibit Thr transport more than Leu or Pro alone (Figure 3C).
This confirmed that they were likely inhibiting the same Thr
transporters.
Determining Relative Transporter Affinities
for the Stronger Thr Inhibitors
Amino acids that inhibited 50 uM Thr uptake most completely
were identified in Figure 2. Of these, the inhibition by Ser,
Ala, non-radiolabeled Thr and Cys were compared at the lower
concentration of 500 uM (Figure 4A). After subtracting Na+-
independent Thr uptake, 500 uM Cys was the strongest inhibitor
tested, with a mean proportion of Thr uptake remaining of only
20% (Figure 4A). However, no statistically significant differences
in inhibition were seen amongst the 500 uM Ser, Ala, Thr, and
Cys (p > 0.05). Even when the Na+-independent component of
transport was not subtracted, the pattern of inhibition was the
same (Figure 4A vs. Figure 4B).
In comparing a second set of more complete inhibitors
identified in Figure 2A (Asn, Met, 3-HNV, and 4-OH-Pro), 500
uM 4-OH-Pro was the strongest inhibitor tested, with a mean
proportion of Thr uptake remaining of 41% after subtracting
Na+-independent Thr transport (Figure 5A). However, no
statistically significant differences in inhibition were found
amongst 500 uM Asn, Met, 3-HNV, and 4-OH-Pro (p >
0.05). The pattern of inhibition was the same even when the
Na+-independent component of transport was not subtracted
FIGURE 3 | Percent uptake of 50 uM [3H]-Thr in the presence of
140mM NaCl and increasing concentrations of (A) Leu (n = 6 for each
point; 3 determinations obtained in each of 2 independent
experiments) or (B) Pro (n = 6 for each point; 3 determinations
obtained in each of 2 independent experiments). Thr uptake was also
measured in the presence of 20mM non-radioactive Thr. A one-way ANOVA
indicated statistically significant differences in [3H]-Thr uptake as the
concentration of Leu and Pro increased. An asterisk (*) signifies significantly
more inhibition by a treatment than the one that precedes it (p < 0.05). (C)
Percent uptake of 50 uM [3H]-Thr in the presence of 140mM NaCl and Leu,
Pro, or Leu and Pro combined (n = 6 for each point; 3 determinations
obtained in each of 2 independent experiments). A one-way ANOVA indicated
no statistically significant differences (p > 0.05) in [3H]-Thr uptake except
between 5mM Pro and 10mM Leu.
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FIGURE 4 | Percent Na+-dependent uptake of 50 uM [3H]-Thr
remaining in the presence of the indicated amino acid (500 uM) (A)
after subtraction of uptake in 140mM Choline Cl. A 1-sample t-test
confirmed that all amino acids tested were s significant inhibitors (*p < 0.05). A
one-way ANOVA indicated no statistically significant difference in [3H]-Thr
uptake in the presence of the different amino acids tested (p > 0.05) (n = 4 for
each column; 2 determinations obtained in each of 2 independent
experiments). (B) Percent uptake of [3H]-Thr remaining in the presence of the
indicated amino acid (500 uM) but without subtraction of Na+-independent
transport. A 1-sample t-test confirmed that all amino acids were statistically
significant inhibitors (*p < 0.05). A one-way ANOVA indicated no statistically
significant difference in [3H]-Thr uptake in the presence of the different amino
acids tested (p > 0.05) (n = 4 for each column; 3 determinations obtained in
each of 2 independent experiments).
(Figure 5A vs. Figure 5B) although inhibition by 4-OH-Pro
was then greater than the other inhibitors tested (p < 0.05)
(Figure 5B). Additionally, although a good inhibitor, 3-HNV
was not one of the strongest inhibitors (Figures 5A,B). For
example, 20mM Ser inhibited [3H]-Thr uptake almost as much
as 20mM non-radiolabeled Thr (Figure 6A), whereas 20mM
3-HNV inhibited [3H]-Thr uptake considerably less completely
than did 20mM non-radiolabeled Thr (p < 0.05; Figure 6B).
Determining mRNA Encoding ASCT1/2 via
RT-PCR
Given the findings from our transport studies, it was likely that
the Na+-dependent transporters, ASCT1 and/or ASCT2, were
responsible for most of the Na+-dependent transport of Thr in
mES cells. Upon conducting RT-PCR and gel electrophoresis, we
FIGURE 5 | Percent Na+-dependent uptake of 50 uM [3H]-Thr
remaining in the presence of the indicated amino acid (500 uM) (A)
after subtraction of uptake in 140mM Choline Cl. A 1-sample t-test
confirmed that all amino acids were statistically significant inhibitors
(*p < 0.05). A one-way ANOVA indicated no statistically significant difference in
[3H]-Thr uptake in the presence of the different amino acids tested (p > 0.05)
(n = 4 for each column; 2 determinations obtained in each of 2 independent
experiments). (B) Percent uptake of [3H]-Thr remaining in the presence of the
indicated amino acid (500 uM) but without subtraction of Na+-independent
transport. A 1-sample t-test confirmed that all amino acids were statistically
significant inhibitors (*p < 0.05). A one-way ANOVA indicated 4-OH-Pro
inhibited [3H]-Thr uptake significantly more than the other amino acids tested
(p < 0.05). (n = 4 for each column; 2 determinations obtained in each of 2
independent experiments).
detected cDNA bands of the size anticipated for both ASCT1
and ASCT2 mRNA (Figure 7). The sequences of the cDNAs
corresponded exactly to the sequences anticipated for those
segments of ASCT1 and ASCT2 mRNA (Molecular Cloning
Laboratories) (Data not shown).
DISCUSSION
mES Cells Express Both Na+-Dependent
and Na+-Independent Components of Thr
Transport
As depicted in the time course studies, Na+-dependent Thr
uptake is considerably more rapid than Na+-independent uptake
Frontiers in Cell and Developmental Biology | www.frontiersin.org 6 March 2016 | Volume 4 | Article 17
Formisano and Van Winkle Transporters Mediating mESC Thr Uptake
FIGURE 6 | Percent uptake of 50 uM [3H]-Thr in the presence of
140mM NaCl and increasing concentrations of (A) Ser or (B) 3-HNV
(n = 6 for each point; 3 determinations obtained in each of 2
independent experiments). Thr uptake was also measured in the presence
of 20mM non-radiolabeled Thr. A 2-sample t-test indicated that [3H]-Thr
uptake in 20mM Ser was not significantly different from [3H]-Thr uptake in
20mM non-radiolabeled Thr (p > 0.05), whereas [3H]- Thr uptake in 20mM
3-HNV was significantly higher than [3H]- Thr uptake in 20mM
non-radiolabeled Thr (p < 0.05). A one-way ANOVA also indicated that 50 uM
[3H]-Thr uptake significantly decreased with increasing concentration of Ser or
3-HNV (p < 0.05).
in mES cells (Figure 1A). Nevertheless, Na+-independent Thr
transport is substrate saturable as there was non-radiolabeled
Thr inhibition of [3H]- Thr transport in the absence of Na+
(Figure 2B). Hence, mES cells express both Na+-dependent and
Na+-independent components of Thr transport.
Amino Acid Inhibition of Na+-Dependent
Thr Transport in mES Cells Resembles
Such Inhibition of Amino Acid Transport
System ASC in Other Cells
Thr, Ser, Cys, 4-OH-Pro, Asn, and Ala were relatively strong
inhibitors of the Na+-dependent [3H]-Thr transport in mES
cells (Figures 2A, 4B, 5B). These amino acids are also relatively
strong inhibitors for the ASCT1 and ASCT2 transports in other
cell types (Utsunomiya-Tate et al., 1996; Yamamoto et al., 2003,
2004). Specifically, both the Na+-dependent Thr transporter(s)
FIGURE 7 | mRNA expression of ASCT1 and ASCT2 in mES cells as
determined by RT-RCR. Lane 1: DNA ladder; Lane 2: ASCT1 primers and
no RNA template control; Lane 3: ASCT1 primers and template RNA; Lane 4:
ASCT2 primers and no template RNA control; Lane 5: ASCT2 primers and
template RNA.
in mES cells and the ASC system transporters have a strong
preference for neutral amino acids without branched or bulky
side chains, with the exception that they tolerate a hydroxyl or
sulfhydryl group at C3 or C4 of the amino acid (Utsunomiya-
Tate et al., 1996; Pinilla-Tenas et al., 2003). Thr, Ser, 3-HNV, Cys,
and 4-OH-Pro, share these characteristics. The hydroxylation
of Pro at C4 greatly increases its affinity for both the ASC
system transporters (Utsunomiya-Tate et al., 1996; Pinilla-Tenas
et al., 2003) and the Na+-dependent component of transport
in mES cells. For example, 0.5mM Pro does not inhibit Thr
uptake (Figure 3B) whereas this concentration of 4-OH-Pro
does inhibit Thr transport (Figure 5B). Asn is another relatively
strong inhibitor of Na+-dependent Thr uptake in both mES cells
(Figures 2A, 5B) and the ASC system in other cells (Utsunomiya-
Tate et al., 1996). While Asn does not have a hydroxyl or
sulfhydryl group, it does have polar groups on C4, similar
to 4-OH-Pro. This could explain its relatively strong inhibitor
properties.
Ala,Met, andGlnwere also good inhibitors of Na+-dependent
Thr uptake (Figures 2A, 4B, 5B). Ala inhibition could be
attributed to its small neutral structure, and both the ASCT1
and ASCT2 transporters are selective for small amino acids
(Utsunomiya-Tate et al., 1996). As for Met and Gln inhibition in
mES cells, ASCT2 (but not ASCT1) has been shown to interact
strongly with both of these amino acids in other cell types
(Utsunomiya-Tate et al., 1996; Bröer et al., 1999). Thus, Alamight
inhibit both Na+-dependent ASCT1 and ASCT2 transporters in
mES cells, while Met and Gln might inhibit mainly ASCT2 in
these cells. This could account for the greater inhibition of Thr
uptake seen by 10mM Ala compared to 10mM Met and Gln
(Figure 2A).
Lastly, 10mM Gly, Leu, Pro, and His were incomplete
inhibitors of Thr uptake in mES cells (Figure 2A), and ASCT2
interacts weakly with these amino acids (Utsunomiya-Tate et al.,
1996). Specifically, Thr uptake decreased as the Leu or Pro
concentration increased to 20mM (Figures 3A,B), indicating
that Leu and Pro were probably inhibiting the same components
of Thr transport. Additionally, since Leu and Pro did not
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inhibit Thr transport more when combined than when studied
separately (Figure 3C), they were probably inhibiting the same
Na+-dependent transporters.
ASCT1 and ASCT2 mRNA are Present in
mES Cells
These findings for Thr transport in mES cells support the theory
that the cells express one or both of the system ASC transporters,
ASCT1 and ASCT2. RT-PCR and sequencing of the cDNA
products confirmed expression of mRNA encoding both ASCT1
and ASCT2 in mES cells (Figure 7). Thus, it is likely that ASCT1
and ASCT2 are responsible for Na+-dependent Thr transport
in mES cells, and that there are at least two components of
Na+-dependent transport in the cells.
Amino Acid Inhibition of Na+-Independent
Thr Transport in mES Cells Resembles
Such Inhibition of Amino Acid Transport
System L in Other Cells
Ser, Leu, Cys, Asn, Met, Gln, Tyr, BCH, and non-radiolabeled
Thr inhibited the Na+-independent component of [3H]-Thr
transport in mES cells (Figure 2B). Such is also the case for
System L transporters in other cell types (Segawa et al., 1999).
Furthermore, both the Na+-independent Thr transporter(s) in
mES cells (Figure 2B) and System L transporters in other cell
types are inhibited strongly and selectively by the Leu analog,
BCH (Segawa et al., 1999; Fukasawa et al., 2000; Fuchs and Bode,
2005). Finally, Tyr inhibited Thr transport only in the absence
of Na+ (Figure 2B). LAT2, a system L transporter with broad
substrate selectivity, also interacts with Tyr (Fukasawa et al.,
2000; Fuchs and Bode, 2005). Thus, the Na+-independent Thr
transporter(s) in mES cells is likely LAT2 or another system L
transporter.
CONCLUSION
This is the first study to characterize Thr transport by mES cells.
Our findings support the conclusion that ASCT1 and ASCT2 are
primarily responsible for the Na+-dependent component of Thr
transport in these cells. Because these two transporters are so
similar, however, studying them independently for Thr transport
in mES cells is difficult. Both are likely present and both probably
play roles in transporting Thr into the cells. While there is also
a Na+-independent component of Thr transport in mES cells,
it was less well characterized in these studies. According to its
transport characteristics, however, it is probably a form of amino
acid transport system L.
Future studies could explore the Na+-independent
component of Thr transport in mES cells in more detail.
Additionally, now that the transporters responsible for the
majority of Thr transport into mES cells have been identified,
future studies should explore the effect Thr transport inhibitors
have on the growth of mES cells. If mES cell growth is arrested
when Thr transport is inhibited by other amino acids such
as Ser, Cys, or Ala, then this would support the conclusion
that Thr transport mediates Thr’s effects in controlling mES
cell proliferation. In this regard, our preliminary studies show
that both Ser and 3-HNV inhibit proliferation of mES cells,
although Ser inhibition is not nearly as strong as that of 3-HNV
(Rasmussen and Van Winkle, personal communication). In
this regard, the stoichiometry of Na+/amino acid cotransport
by system ASC varies from 4.5 to 0.22 depending on the
structure of the amino acid (Van Winkle, 2001). Such variable
interactions of amino acids with the ASC transport protein
could also mean that they influence signaling initiated by the
protein (Ryu and Han, 2011) in different ways or to varying
extents. Moreover, it would be interesting in future studies
to knockdown either or both ASCT1 or ASCT2 expression
and measure the effects of such knockdowns on mES cell
proliferation.
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